π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
Leptomeningeal metastasis (LM) is a devastating and terminal complication o...
Status
Unknown
Location
Multiple Locations
Start Date
2019-11-01
Trial ID
NCT04148898
Treatments Being Tested
This is a single-center, open-label, phase I clinical trial aimed to evalua...
Status
Unknown
Location
Tianjin Medical University Cancer Institute and Hospital
Start Date
2021-08-01
Trial ID
NCT05507606
Treatments Being Tested
In this study, investigators utilize a radiopathomics integrated Artificial...
Status
Unknown
Location
Gastrointestinal Department of First Affiliated Hospital of Zhejiang University
Start Date
2024-07-01
Trial ID
NCT06396143
This clinical trial is evaluating tucatinib in combination with Doxil in pa...
Status
Recruiting
Location
Maryland Oncology Hematology
Start Date
2023-07-24
Trial ID
NCT05748834
This first-in-human open-label, multi center, dose-escalation and expansion...
Status
Terminated
Location
Liverpool Hospital
Start Date
2021-10-29
Trial ID
NCT05073484
This is a pilot phase 1b study to investigate the safety and side effects o...
Status
Completed
Location
University of California, San Diego
Start Date
2018-08-15
Trial ID
NCT02776917
Treatments Being Tested
The purpose of this study is to test the safety of a combination of two ant...
Status
Completed
Location
Center for Lymphoid Malignancies at CUMC
Start Date
2008-06
Trial ID
NCT00691210
Treatments Being Tested
This clinical study is a single arm, prospective, single center clinical st...
Status
Unknown
Location
The Comprehensive Cancer Centre of Nanjing Drum Tower Hospital, Medical School of Nanjing University & Clinical Center Institute of Nanjing University, Nanjing, China
Start Date
2023-05-01
Trial ID
NCT06512896
Treatments Being Tested
This is a Phase 1/2 study of the combination of Ad-p53 administered intra-a...
Status
Terminated
Location
MD Anderson Cancer Center
Start Date
2018-11-20
Trial ID
NCT02842125
This is an open-label, multicenter, Phase Ib study to determine the maximum...
Status
Completed
Location
Rigshospitalet
Start Date
2021-07-14
Trial ID
NCT04826003
Treatments Being Tested